Growth Metrics

Oncology Institute (DFPH) Long-Term Deferred Tax (2019 - 2020)

Oncology Institute posted quarterly Long-Term Deferred Tax of $70000.0 for Q3 2020, up 79.49% on a QoQ basis from $39000.0 in Q2 2020.

Oncology Institute (DFPH) has 2 years of Long-Term Deferred Tax data on file, last reported at $70000.0 in Q3 2020.

  • For the quarter ending Q3 2020, Long-Term Deferred Tax changed N/A year-over-year to $70000.0; the trailing twelve-month figure through Sep 2020 stood at $70000.0 (changed N/A YoY), and the FY2019 full-year result was $300.0, changed N/A from the prior year.
  • Long-Term Deferred Tax for Q3 2020 stood at $70000.0, up from $39000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $70000.0 in Q3 2020 and bottomed at $300.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Oncology Institute - - 139.16 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 70,000.00
Jun 30, 2020 39,000.00
Dec 31, 2019 300.00